- Especificar que la novel formulation es una fixed-dose coformulation de [[Ivermectina]] y [[Albendazol]].
- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest level of investment risk of all candidates for Combi
- Especificar que esta fixed-dose coformulation de ivm/alb has the lowest level of investment risk of all candidates for Combinations for STH treatment (fuente: Soil Transmitted Helminths Drug Combinations Expert Meeting, 2016, Gates Foundation)